These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1403398)

  • 1. Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia.
    Watts CL; Bruce MC
    J Pediatr; 1992 Oct; 121(4):597-607. PubMed ID: 1403398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia.
    Watts CL; Fanaroff AA; Bruce MC
    J Pediatr; 1992 Apr; 120(4 Pt 1):614-20. PubMed ID: 1552403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants.
    Watts CL; Bruce MC
    J Pediatr; 1995 Jul; 127(1):113-22. PubMed ID: 7608795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracheal lavage and plasma fibronectin: relationship to respiratory distress syndrome and development of bronchopulmonary dysplasia.
    Gerdes JS; Yoder MC; Douglas SD; Paul M; Harris MC; Polin RA
    J Pediatr; 1986 Apr; 108(4):601-6. PubMed ID: 3958835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dexamethasone in the treatment of bronchopulmonary dysplasia].
    Schrod L; Frauendienst-Egger G; Forgber I; von Stockhausen HB
    Pneumologie; 1991 Nov; 45(11):892-6. PubMed ID: 1762998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia.
    Yoder MC; Chua R; Tepper R
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):1044-8. PubMed ID: 2024813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dexamethasone and indomethacin on elastase, alpha 1-proteinase inhibitor, and fibronectin in bronchoalveolar lavage fluid from neonates.
    Gerdes JS; Harris MC; Polin RA
    J Pediatr; 1988 Oct; 113(4):727-31. PubMed ID: 2459363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants.
    Zhu H; Tian Y; Cheng H; Zheng Y; Wang W; Bao T; Wu R; Tian Z
    Int J Med Sci; 2021; 18(12):2581-2588. PubMed ID: 34104089
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of dexamethasone on respirator-dependent very-low-birth-weight infants is best predicted by chest X-ray.
    Schrod L; Neuhaus T; Horwitz AE; Speer CP
    Pediatr Radiol; 2001 May; 31(5):332-8. PubMed ID: 11373920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower concentration of pulmonary hepatocyte growth factor is associated with more severe lung disease in preterm infants.
    Lassus P; Heikkilä P; Andersson LC; von Boguslawski K; Andersson S
    J Pediatr; 2003 Aug; 143(2):199-202. PubMed ID: 12970632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble E-selectin, soluble L-selectin and soluble ICAM-1 in bronchopulmonary dysplasia, and changes with dexamethasone.
    Ballabh P; Kumari J; Krauss AN; Shin JJ; Jain A; Auld PA; Lesser ML; Cunningham-Rundles S
    Pediatrics; 2003 Mar; 111(3):461-8. PubMed ID: 12612222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pepsin, a marker of gastric contents, is increased in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
    Farhath S; He Z; Nakhla T; Saslow J; Soundar S; Camacho J; Stahl G; Shaffer S; Mehta DI; Aghai ZH
    Pediatrics; 2008 Feb; 121(2):e253-9. PubMed ID: 18245400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone therapy in severe bronchopulmonary dysplasia.
    Bourchier D
    Aust Paediatr J; 1988 Feb; 24(1):41-4. PubMed ID: 3355444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticosteroids in the prevention and management of bronchopulmonary dysplasia.
    Grier DG; Halliday HL
    Semin Neonatol; 2003 Feb; 8(1):83-91. PubMed ID: 12667833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
    Kari MA; Heinonen K; Ikonen RS; Koivisto M; Raivio KO
    Arch Dis Child; 1993 May; 68(5 Spec No):566-9. PubMed ID: 8323356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin A status and postnatal dexamethasone treatment in bronchopulmonary dysplasia.
    Shenai JP; Mellen BG; Chytil F
    Pediatrics; 2000 Sep; 106(3):547-53. PubMed ID: 10969101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
    Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
    Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary endostatin perinatally and in lung injury of the newborn infant.
    Janér J; Andersson S; Haglund C; Lassus P
    Pediatrics; 2007 Jan; 119(1):e241-6. PubMed ID: 17158946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia.
    Ng PC; Brownlee KG; Kelly EJ; Henderson MJ; Smith M; Dear PR
    Arch Dis Child; 1992 Oct; 67(10 Spec No):1193-5. PubMed ID: 1444557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuin1 in tracheal aspirate leukocytes: possible role in the development of bronchopulmonary dysplasia in premature infants.
    Mody K; Saslow JG; Kathiravan S; Eydelman R; Bhat V; Stahl GE; Pyon K; Bhandari V; Aghai ZH
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1483-7. PubMed ID: 22272724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.